227 related articles for article (PubMed ID: 18333850)
21. Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.
Marks DI; Pagliuca A; Kibbler CC; Glasmacher A; Heussel CP; Kantecki M; Miller PJ; Ribaud P; Schlamm HT; Solano C; Cook G;
Br J Haematol; 2011 Nov; 155(3):318-27. PubMed ID: 21880032
[TBL] [Abstract][Full Text] [Related]
22. Voriconazole and itraconazole in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction.
Kramer MR; Amital A; Fuks L; Shitrit D
Clin Transplant; 2011; 25(2):E163-7. PubMed ID: 21158923
[TBL] [Abstract][Full Text] [Related]
23. A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
Selleslag D
Acta Biomed; 2006; 77 Suppl 2():32-5. PubMed ID: 16918066
[TBL] [Abstract][Full Text] [Related]
24. Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia.
Yang L; Yu L; Chen X; Hu Y; Wang B
Med Sci Monit; 2015 Jun; 21():1656-61. PubMed ID: 26050202
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.
Groll AH; Kolve H; Ehlert K; Paulussen M; Vormoor J
J Antimicrob Chemother; 2004 Jan; 53(1):113-4. PubMed ID: 14657088
[TBL] [Abstract][Full Text] [Related]
26. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.
Jeng MR; Feusner J
Pediatr Hematol Oncol; 2001 Mar; 18(2):137-42. PubMed ID: 11255732
[TBL] [Abstract][Full Text] [Related]
27. Antifungal Prophylaxis With Posaconazole Is Effective in Preventing Invasive Fungal Infections in Acute Myeloid Leukemia Patients During Induction and Salvage Chemotherapy.
Wong GC; Abdul Halim NA; Tan BH
Clin Infect Dis; 2015 Oct; 61(8):1351-2. PubMed ID: 26139846
[No Abstract] [Full Text] [Related]
28. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
Vadnerkar A; Nguyen MH; Mitsani D; Crespo M; Pilewski J; Toyoda Y; Bermudez C; Kwak EJ; Silveira FP; Clancy CJ
J Heart Lung Transplant; 2010 Nov; 29(11):1240-4. PubMed ID: 20591690
[TBL] [Abstract][Full Text] [Related]
29. Clinical effectiveness of itraconazole as antifungal prophylaxis in AML patients undergoing intensive chemotherapy in the modern era.
Keighley CL; Manii P; Larsen SR; van Hal S
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):213-217. PubMed ID: 27830376
[TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation.
Sánchez-Ortega I; Patiño B; Arnan M; Peralta T; Parody R; Gudiol C; Encuentra M; Fernández de Sevilla A; Duarte RF
Bone Marrow Transplant; 2011 May; 46(5):733-9. PubMed ID: 20697369
[TBL] [Abstract][Full Text] [Related]
31. Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
Okamoto T; Koh K; Takita J; Furuya A; Kato M; Ida K
Pediatr Int; 2010 Feb; 52(1):137-41. PubMed ID: 20158658
[No Abstract] [Full Text] [Related]
32. Fatal Scedosporium prolificans infection in a paediatric patient with acute lymphoblastic leukaemia.
Song MJ; Lee JH; Lee NY
Mycoses; 2011 Jan; 54(1):81-3. PubMed ID: 19664020
[TBL] [Abstract][Full Text] [Related]
33. Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
Sagnelli C; Fumagalli L; Prigitano A; Baccari P; Magnani P; Lazzarin A
J Antimicrob Chemother; 2006 Apr; 57(4):796-8. PubMed ID: 16469850
[No Abstract] [Full Text] [Related]
34. Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies.
Böhme A; Just-Nübling G; Bergmann L; Shah PM; Stille W; Hoelzer D
J Antimicrob Chemother; 1996 Dec; 38(6):953-61. PubMed ID: 9023642
[TBL] [Abstract][Full Text] [Related]
35. A controlled clinical trial of itraconazole for prevention of fungal infections secondary to chemotherapy.
Wang CY; Wu BY; Guo KY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):389-90. PubMed ID: 12697487
[TBL] [Abstract][Full Text] [Related]
36. Posaconazole prophylaxis in hematologic cancer.
van Nieuwkoop C; van Dissel JT
N Engl J Med; 2007 May; 356(21):2215; author reply 2215-8. PubMed ID: 17526089
[No Abstract] [Full Text] [Related]
37. Successful treatment of gastrointestinal mucormycosis in an adolescent with acute lymphoblastic leukaemia (ALL).
Aabideen K; Lashkari HP; Holmes K; Taj M
Pediatr Blood Cancer; 2012 Feb; 58(2):312-3. PubMed ID: 21793182
[No Abstract] [Full Text] [Related]
38. Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.
Burkhardt O; Thon S; Burhenne J; Welte T; Kielstein JT
Int J Antimicrob Agents; 2010 Jul; 36(1):93-4. PubMed ID: 20381320
[No Abstract] [Full Text] [Related]
39. Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients.
Cordonnier C; Rovira M; Maertens J; Cornely OA; Ljungman P; Einsele H;
Haematologica; 2011 Feb; 96(2):e9-10; author reply e11. PubMed ID: 21282716
[No Abstract] [Full Text] [Related]
40. Why do lung transplant patients discontinue triazole prophylaxis?
Pennington KM; Razonable RR; Peters S; Scott JP; Wylam M; Daly RC; Kennedy CC
Transpl Infect Dis; 2019 Jun; 21(3):e13067. PubMed ID: 30866168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
